PRESCRIBING · PART D · 2024
Total Rx claims
1,197
Beneficiaries
—
Total drug cost
$161K
Distinct drugs
41
Brand share
26.2%
Top prescribed drugs
Lisinopril118 claims
Atorvastatin Calcium116 claims
Rosuvastatin Calcium83 claims
Semaglutide64 claims
Losartan Potassium61 claims
QUALITY · MIPS · 2024
Final MIPS score
83.7
Quality
68.3
Cost
87.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.36%
Group
CROSS-REFERENCE